Ceva Completes Deal to Acquire Portfolio of Merial Swine Vaccines and Nonsteroidal Anti-Inflammatories from Boehringer Ingelheim
GLOBAL - Ceva Santé Animale today completed the acquisition of a diversified portfolio of products, including swine and cattle vaccines and multi-species nonsteroidal anti-inflammatories from Boehringer Ingelheim following its acquisition of Merial Animal Health.